Furthermore, this study revealed that 39.9% of patients with normal ALT and an age < 40 years have significant liver fibrosis, which indicates that more rigorous monitoring of liver fibrosis is also necessary for patients aged < 40 years, and more data are needed in the future to investigate the relationship between age and the immune tolerance phase. Here, GPT is linked to Hepatic fibrosis.